RPRXRoyalty Pharma plc

RPRX Stock Price, Valuation & Chart | Royalty Pharma plc

Compare

$60.960+1.34 (+2.25%)

At close · 16 Oct 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology

Overview Financials Dividends Ratios

RPRX Historical price chart

RPRX Key Stats

Market Capitalization27.14B

PE Ratio11.61

EPS5.25

Trading Volume5.79M

Today's High/Low61.31/59.63

Dividend Yield1.52

52 Week High/Low64.38/35.91

Shares Outstanding445.28M

RPRX Financial Statement

RPRX Analyst ratings

RPRX Analysis & performance metrics

RPRX Company profile

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved…

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and…

RPRX Management team

Name

Position

James Folmar Reddoch Ph.D.

Executive Vice President of Investments & Chief Scientific Officer

Eric Cornelius SchneiderCTO

Senior Vice President & Chief Technology Officer

Kristin Stafford

Senior Vice President & Chief Accounting Officer

Ashwin Pai M.D.

Executive Vice President of Investments

Christopher Hite

Vice Chairman & Executive Vice President

Pablo Gerardo LegorretaCEO

Founder, Chairman of the Board & Chief Executive Officer

Marshall Jonathan Urist M.D., Ph.D.

Executive Vice President of Research & Investments

Arthur Richard McGivern J.D.

Executive Vice President of Investments & General Counsel

Name

Position

James Folmar Reddoch Ph.D.

Executive Vice President of Investments & Chief Scientific Officer

Eric Cornelius SchneiderCTO

Senior Vice President & Chief Technology Officer

Kristin Stafford

Senior Vice President & Chief Accounting Officer

Ashwin Pai M.D.

Executive Vice President of Investments

Christopher Hite

Vice Chairman & Executive Vice President

Pablo Gerardo LegorretaCEO

Founder, Chairman of the Board & Chief Executive Officer

Marshall Jonathan Urist M.D., Ph.D.

Executive Vice President of Research & Investments

Arthur Richard McGivern J.D.

Executive Vice President of Investments & General Counsel

Management Team

James Folmar Reddoch Ph.D.

Executive Vice President of Investments & Chief Scientific Officer

Eric Cornelius SchneiderCTO

Senior Vice President & Chief Technology Officer

Kristin Stafford

Senior Vice President & Chief Accounting Officer

Ashwin Pai M.D.

Executive Vice President of Investments

Christopher Hite

Vice Chairman & Executive Vice President

Pablo Gerardo LegorretaCEO

Founder, Chairman of the Board & Chief Executive Officer

Marshall Jonathan Urist M.D., Ph.D.

Executive Vice President of Research & Investments

Arthur Richard McGivern J.D.

Executive Vice President of Investments & General Counsel

Management

James Folmar Reddoch Ph.D.

Executive Vice President of Investments & Chief Scientific Officer

Eric Cornelius SchneiderCTO

Senior Vice President & Chief Technology Officer

Kristin Stafford

Senior Vice President & Chief Accounting Officer

Ashwin Pai M.D.

Executive Vice President of Investments

Christopher Hite

Vice Chairman & Executive Vice President

Pablo Gerardo LegorretaCEO

Founder, Chairman of the Board & Chief Executive Officer

Marshall Jonathan Urist M.D., Ph.D.

Executive Vice President of Research & Investments

Arthur Richard McGivern J.D.

Executive Vice President of Investments & General Counsel

Total 8 executives

RPRX Frequently asked questions

What is Royalty Pharma plc (RPRX) Stock Price?

Current stock price of Royalty Pharma plc (RPRX) stock is $60.960. The stock price is +2.25% higher in the session. The intraday range can be seen from this page. Volume of Royalty Pharma plc (RPRX) stock is 5.79M.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the Royalty Pharma plc (RPRX) stock price going up or down today?

The stock price of Royalty Pharma plc (RPRX) can change with earnings, company news, and overall market sentiment. Royalty Pharma plc operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Royalty Pharma plc stock expensive at its current price?

Whether Royalty Pharma plc looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for RPRX on this page is 11.61. EPS on this page is 5.25. Compare those figures with peers and growth expectations before deciding if the current Royalty Pharma plc price is justified.

How has the stock price of Royalty Pharma plc (RPRX) performed historically?

Historical performance for Royalty Pharma plc (RPRX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how RPRX reacted to past earnings and market events.

Should I buy Royalty Pharma plc (RPRX) stock, at this price?

Buying Royalty Pharma plc (RPRX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.